(Louis) Dog Called Kitty, A (Large Print)
by American Printing House for the Blind
Last verified June 15, 2026 · classified June 15, 2026
What it is
Summary
AI-generated from vendor-published content · June 15, 2026
A large-print edition of the children's novel 'A Dog Called Kitty' by Bill Wallace, produced by the American Printing House for the Blind for students and readers with low vision who need oversized text to access printed books independently. APH large-print books use enlarged typefaces and high-contrast formatting specifically calibrated for readers with visual impairments, making them meaningfully different from standard commercial paperbacks. This is a complete, ready-to-read book — no additional equipment or setup required. Federal Quota funds are available for this title, which means eligible students in the U.S. can often receive it at no cost through their state's APH quota allotment rather than paying out of pocket.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
- School district
What Setup Looks Like
- Out of the box
- Open the book and begin reading — no setup required.
- If using Federal Quota funds, coordinate with your school's APH quota coordinator to place the order at no direct cost.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blind — view on vendor site; last verified June 15, 2026.
Classification & description AI-generated from vendor-published content on June 15, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.